AI-assisted international press reviewPress review

TÜV SÜD Validates Sumitomo Chemical's CFP-TOMO® Carbon Footprint Tool

The carbon footprint calculation tool CFP-TOMO®, developed by Sumitomo Chemical, has recently received validation from TÜV SÜD, confirming its compliance with international standards. This validation is crucial for helping companies visualize their greenhouse gas emissions and achieve carbon neutrality goals. Sumitomo Chemical is committed to promoting this tool to facilitate transparency and communication of carbon footprint calculations within the chemical industry.

Source: Sumitomo Chemical, published under the title "Sumitomo Chemical's Carbon Footprint of Product Calculation ..." - 29 September 2026

Energy & Construction

Celebrating 30 Years of Partnership in the Philippines: A Look at Infrastructure Projects

Leighton Asia marks three decades of collaboration in the Philippines while announcing major infrastructure projects, including mining contracts in Cambodia and initiatives to promote women in engineering. These developments highlight the company's commitment to innovation and support for future generations of professionals in the construction sector.

Source: Cimic, published under the title "Celebrating 30 years of partnership in the Philippines" - 29 September 2026

Agrifood

Bubly™ Launches New Halloween Flavors to Meet Consumer Demand

Bubly™ introduces three limited-edition flavors for Halloween, catering to the growing consumer demand for sugar-free beverages. The 222 mL cans, available until October 31, 2026, include boo-berry lime, blood orange, and tropical potion, all calorie-free and free from sweeteners, aligning with the trend of mini can formats favored by Canadians.

Source: Pepsico, published under the title "bubly™ sparkling water launches three new flavours in mini c..." - 29 September 2026

Health

AstraZeneca Invests $2 Billion in Summit Therapeutics for Oncology Development

AstraZeneca announces a strategic investment of $2 billion in Summit Therapeutics to accelerate the development of ivonescimab, an innovative bispecific antibody, in combination with antibody-drug conjugates (ADCs) for the treatment of gastrointestinal cancers. This collaboration aims to expand the portfolio of therapeutic options for patients with various types of cancer while maintaining development rights for each company.

Source: Astrazeneca, published under the title "AstraZeneca announces strategic equity investment and clinic..." - 29 September 2026

Ben's Original and Ben Rice: 500,000 Meals for Children in Need

The collaboration between Ben's Original and baseball player Ben Rice has provided significant support to children facing food insecurity, transforming athletic performances into concrete actions for the community. Thanks to No Kid Hungry, this initiative has facilitated access to 500,000 meals, illustrating the positive impact that sports can have on essential social causes.

Source: Mars Incorporated, published under the title "Ben's Original and Ben Rice Help Kids Access up to 500,000 M..." - 28 September 2026

Energy & Construction

Iberdrola Strengthens Its Position in Spain with Contigo Energía Acquisition

Iberdrola has finalized an agreement to acquire the retail operations of Contigo Energía, adding over 100,000 customers to its portfolio. This acquisition aligns with Iberdrola's strategy to expand its retail business in Spain, aiming to enhance its leadership and promote the electrification of the energy system. Contigo Energía will continue to operate independently within the group, as Niba since its launch in June 2025.

Source: Iberdrola, published under the title "Iberdrola adds 100,000 electricity customers in Spain follow..." - 28 September 2026

Health

Bayer's Lynkuet™ Receives FDA Priority Review for Innovative Treatment

The FDA has granted priority review to Lynkuet™ for the treatment of vasomotor symptoms in women undergoing endocrine therapy for breast cancer, marking a significant advancement in managing the side effects of this therapy. The results of the OASIS-4 study highlight the effectiveness of this treatment, which could transform the quality of life for millions of women. Meanwhile, Bayer continues to expand its treatment options to meet the needs of women worldwide.

Source: Bayer, published under the title "Bayer’s Lynkuet™ (elinzanetant) granted priority review by U..." - 28 September 2026

Agrifood

Tyson Foods Reports Strong Q3 2026 Results and Growth Outlook

Tyson Foods announced solid financial results for the third quarter of 2026, with increased sales and profits driven by the performance of its chicken and prepared foods segments. The forecasts for fiscal year 2026 indicate continued growth in protein production, reinforcing the company's market position. CEO Donnie King emphasizes the importance of operational excellence and customer partnerships in this growth dynamic.

Source: Tyson Foods, published under the title "Tyson Foods Reports Third Quarter 2026 Results" - 28 September 2026

Agrifood

Tyson Foods Invests $1 Million to Enhance School Nutrition

Tyson Foods has announced a $1 million commitment over two years to support the Harvest to Hallways initiative, aimed at improving access to healthy meals for children and enhancing nutrition education in schools, particularly in rural areas. This funding will be distributed through partnerships with recognized organizations, emphasizing the importance of nourishing youth for their development.

Source: Tyson Foods, published under the title "Tyson Foods Commits $1 Million to Support School Nutrition a..." - 28 September 2026

Agrifood

Tyson Foods Restructures Beef Production Network Amid Cattle Shortage

Tyson Foods announces a restructuring of its beef operations, focusing on three key facilities in the central United States to address a historic cattle shortage. The closure of certain plants and the sale of others are part of this strategy aimed at maintaining efficient and modern production while supporting employees affected by these changes.

Source: Tyson Foods, published under the title "Tyson Foods Announces Network Restructuring for Beef Busines..." - 28 September 2026

Soils, Inputs & Water

Yara Awards the 2026 Birkeland Prize to Dr. Mateusz Sowiński

Dr. Mateusz Sowiński has been honored with the 2026 Birkeland Prize by Yara for his significant contributions to sustainable agriculture and plant technologies. This award highlights the importance of scientific innovation in transforming agricultural practices and seeking sustainable solutions to environmental challenges. Dr. Sowiński's work focuses on optimizing agricultural yields through advanced technological approaches, aligning with current agritech issues.

Source: Yara, published under the title "Yara’s Birkeland Prize 2026 goes to Dr. Mateusz Sowiński" - 26 September 2026

Health

Imfinzi and Enfortumab Vedotin: Priority Review for Bladder Cancer Treatment

AstraZeneca has received a priority review from the FDA for Imfinzi in combination with enfortumab vedotin, aimed at treating muscle-invasive bladder cancer. Results from the Phase III VOLGA trial show significant improvements in survival, providing a new option for patients ineligible for traditional chemotherapy. This treatment could redefine care standards in this field, addressing an urgent need for new therapeutic alternatives.

Source: Astrazeneca, published under the title "Perioperative Imfinzi plus neoadjuvant enfortumab vedotin gr..." - 25 September 2026

Health

TREMFYA: Significant Advances in Treating Axial Psoriatic Arthritis

Johnson & Johnson announces that TREMFYA has met the primary endpoints of the STAR study, demonstrating improvement in axial symptoms and a reduction in inflammation in patients with axial psoriatic arthritis. These results mark a significant advancement in research on this condition, highlighting the urgent need for effective treatments for patients suffering from spinal pain and stiffness.

Source: J&j - 25 September 2026

Health

CARVYKTI®: Promises of Durable Remissions in Multiple Myeloma

Johnson & Johnson revealed that 50% of patients with refractory or relapsed multiple myeloma treated with CARVYKTI® achieved progression-free survival of at least five years. These results, presented at the annual meeting of the International Myeloma Society, suggest that early treatment could enhance long-term remission chances, reinforcing the idea of a potential cure for some patients, even those with high-risk disease characteristics.

Source: J&j - 25 September 2026

Energy & Construction

ScottishPower Recognized for Social and Environmental Commitment in the UK

ScottishPower, a subsidiary of Iberdrola, has been honored for its corporate social responsibility initiatives, highlighting its positive impact on local communities and commitment to sustainable development. The programs include access to employment, combating energy poverty, and supporting vulnerable groups, while promoting biodiversity conservation and recycling of renewable energy components. This award reflects the company's dedication to a fairer and more sustainable future.

Source: Iberdrola, published under the title "Iberdrola recognised for its social and environmental commit..." - 25 September 2026

Soils, Inputs & Water

Mary-Dell Chilton, Pioneer of Biotechnology, Receives National Medal of Technology

Mary-Dell Chilton, former researcher at Syngenta, has been honored by President Biden for her significant contributions to plant biotechnology, including the creation of the first transgenic plant. This award adds to a long list of accolades that reflect her impact on modern agriculture and technological innovation in the sector.

Source: Sygenta Group, published under the title "Syngenta Group announces Mary-Dell Chilton awarded National ..." - 25 September 2026

Soils, Inputs & Water

Syngenta Group Strengthens Collaborations for Innovative Agricultural Solutions

Syngenta Group, a global leader in agricultural technology, announces strategic partnerships with IBM and Maxygen to develop innovative solutions to agricultural challenges. These collaborations aim to optimize chemical synthesis and enhance protein technologies, while inviting other stakeholders to participate in innovation challenges through its Shoots platform.

Source: Sygenta Group, published under the title "Syngenta Group expands collaborations for more innovative sc..." - 25 September 2026

Soils, Inputs & Water

Syngenta Group Withdraws IPO Plans in China Amid Market Conditions

Syngenta Group, a major player in agritech innovation, has decided to withdraw its initial public offering (IPO) application on the Shanghai Stock Exchange, while reaffirming its commitment to sustainable global agriculture and its intention to strengthen its market position. The company plans to relaunch its IPO when conditions are favorable and is exploring other financing options to support its growth strategy.

Source: Sygenta Group, published under the title "Syngenta Group update on its IPO" - 25 September 2026

Soils, Inputs & Water

Syngenta Group Named Top Agricultural Employer for 7th Consecutive Year in 2023

Syngenta Group, recognized by Science magazine as the top agricultural employer, emphasizes innovation and talent attraction to tackle global food challenges. With an investment of $1.48 billion in R&D, the company is committed to developing advanced technologies for sustainable agriculture while employing 59,000 people worldwide.

Source: Sygenta Group, published under the title "Syngenta Group recognized as top agriculture employer for th..." - 25 September 2026

Soils, Inputs & Water

Hengde Qin Appointed Chief Financial Officer of Syngenta Group

Syngenta Group announces the appointment of Hengde Qin as Chief Financial Officer, a strategic role aimed at supporting innovation and growth in the plant technology and agrifood sectors. This decision is part of a broader transformation of production models and the industrialization of agritech practices, thereby strengthening Syngenta's position in the global market.

Source: Sygenta Group, published under the title "Hengde Qin named Chief Financial Officer of Syngenta Group" - 25 September 2026